Review Assesses Combining Antibody-Drug Conjugates With Checkpoint Inhibitors Across Cancer Types
A review in Molecular Cancer examines how antibody-drug conjugates combined with checkpoint inhibitors influence antitumor immunity and trial outcomes across ...















